5-Oxo-hexahydroquinoline: an attractive scaffold with diverse biological activities

Mol Divers. 2019 May;23(2):471-508. doi: 10.1007/s11030-018-9886-4. Epub 2018 Nov 2.

Abstract

5-Oxo-hexahydroquinoline (5-oxo-HHQ) represents a biologically attractive fused heterocyclic core. Various synthetic analogs of 5-oxo-HHQ have been synthesized and assessed for different biological activities. Some derivatives have exhibited myorelaxant, analgesic, anticancer, antibacterial, antifungal, antitubercular, antimalarial, antioxidant, anti-inflammatory, multidrug resistance reversal, anti-Alzheimer, neuroprotective, antidiabetic, antidyslipidemic and antiosteoporotic activities. This review provides a comprehensive report regarding the preparation and pharmacological characterization of 5-oxo-HHQ derivatives that have been reported so far. This information will be beneficial for medicinal chemists in the field of drug discovery to design and develop new and potent therapeutical agents bearing the 5-oxo-HHQ nucleus.

Keywords: 5-Oxo-hexahydroquinoline; Anticancer; Biological effects; Medicinal chemistry; Multicomponent reaction; Structure–activity relationship.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacology
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / pharmacology
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Humans
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology
  • Hypolipidemic Agents / chemistry
  • Hypolipidemic Agents / pharmacology
  • Parasympatholytics / chemistry
  • Parasympatholytics / pharmacology
  • Quinolines / chemistry*
  • Quinolines / pharmacology*

Substances

  • 5-oxo-hexahydroquinoline
  • Anti-Infective Agents
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Parasympatholytics
  • Quinolines